NAGE

Niagen Bioscience, Inc. Common Stock

46 hedge funds and large institutions have $14.7M invested in Niagen Bioscience, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 7 increasing their positions, 14 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
46
Holders Change
Holders Change %
0%
% of All Funds
1.15%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
16
Increased
7
Reduced
14
Closed
16
Calls
$1K
Puts
$47K
Net Calls
-$46K
Net Calls Change
-$46K
Name Holding Trade Value Shares
Change
Shares
Change %
Charles Schwab
51
Charles Schwab
California
-$121K -44,800 Closed
Invesco
52
Invesco
Georgia
-$61K -22,638 Closed
JPMorgan Chase & Co
53
JPMorgan Chase & Co
New York
-$52K -19,406 Closed
NFA
54
Nationwide Fund Advisors
Ohio
-$50K -18,670 Closed
AIG
55
American International Group
New York
-$47K -17,628 Closed
LPL Financial
56
LPL Financial
California
-$33K -12,334 Closed
Commonwealth Equity Services
57
Commonwealth Equity Services
Massachusetts
-$27K -10,002 Closed
New York State Common Retirement Fund
58
New York State Common Retirement Fund
New York
-$20K -7,401 Closed
Legal & General Group
59
Legal & General Group
United Kingdom
-$13K -4,744 Closed
AIP
60
Ameritas Investment Partners
Nebraska
-$6K -2,230 Closed
Royal Bank of Canada
61
Royal Bank of Canada
Ontario, Canada
-$3K -1,097 Closed